Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Thermo Fisher Scientific stock in Canada | $611.96

Own Thermo Fisher Scientific shares in just a few minutes.

Thermo Fisher Scientific Inc
NYSE: TMO - USD
DIAGNOSTICS & RESEARCH
$611.96
+ $3.55 ( + 0.58%)

Thermo Fisher Scientific Inc is a diagnostics & research business based in the US. Thermo Fisher Scientific shares (TMO) are listed on the NYSE and all prices are listed in US Dollars. Thermo Fisher Scientific employs 80,000 staff and has a trailing 12-month revenue of around USD$38.3 billion.

How to buy shares in Thermo Fisher Scientific

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TMO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Thermo Fisher Scientific stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Thermo Fisher Scientific's stock price?

Since the stock market crash in March caused by coronavirus, Thermo Fisher Scientific's stock price has had significant positive movement.

Its last market close was $611.96, which is 45.27% up on its pre-crash value of $334.94 and 144.58% up on the lowest point reached during the March crash when the stocks fell as low as $250.21.

If you had bought $1,000 worth of Thermo Fisher Scientific stocks at the start of February 2020, those stocks would have been worth $801.64 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,921.55.

Thermo Fisher Scientific stock price

Use our graph to track the performance of TMO stocks over time.

Thermo Fisher Scientific shares at a glance

Information last updated 2021-10-23.
Latest market close$611.96
52-week range$432.83 - $616.93
50-day moving average $582.20
200-day moving average $519.72
Wall St. target price$653.61
PE ratio 28.3433
Dividend yield $0.96 (0.16%)
Earnings per share (TTM) $21.59

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
FREE TRADES
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get 2 free stocks when you open a Wealthsimple Trade personal account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
BMO InvestorLine
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$9.95
$9.95 + $1.25 per options contract
$0 if conditions met, otherwise $25/quarter
$0 - $9.95
Buy and sell a select group of Canada’s most popular ETFs without paying commissions.
An easy-to-use online trading platform with access to research, tools, and the option to access InvestorLine adviceDirect for additional professional support.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
OFFER
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until December 31, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Thermo Fisher Scientific price performance over time

Historical closes compared with the close of $611.96 from 2021-10-22

1 week (2021-10-18) 4.07%
1 month (2021-09-24) 0.36%
3 months (2021-07-23) 14.97%
6 months (2021-04-23) 25.38%
1 year (2020-10-23) 27.45%
2 years (2019-10-24) 108.55%
3 years (2018-10-24) 177.46%
5 years (2016-10-24) 299.69%

Is Thermo Fisher Scientific under- or over-valued?

Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Thermo Fisher Scientific's P/E ratio

Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Thermo Fisher Scientific shares trade at around 28x recent earnings.

That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).

Thermo Fisher Scientific's PEG ratio

Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.5641. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Thermo Fisher Scientific's EBITDA

Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.3 billion.

The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure a its profitability.

Thermo Fisher Scientific financials

Revenue TTM $38.3 billion
Operating margin TTM 28.37%
Gross profit TTM $16 billion
Return on assets TTM 10.49%
Return on equity TTM 25.76%
Profit margin 22.47%
Book value $93.68
Market capitalisation $240.8 billion

TTM: trailing 12 months

Shorting Thermo Fisher Scientific shares

There are currently 2.6 million Thermo Fisher Scientific shares held short by investors – that's known as Thermo Fisher Scientific's "short interest". This figure is 4.1% down from 2.7 million last month.

There are a few different ways that this level of interest in shorting Thermo Fisher Scientific shares can be evaluated.

Thermo Fisher Scientific's "short interest ratio" (SIR)

Thermo Fisher Scientific's "short interest ratio" (SIR) is the quantity of Thermo Fisher Scientific shares currently shorted divided by the average quantity of Thermo Fisher Scientific shares traded daily (recently around 1.5 million). Thermo Fisher Scientific's SIR currently stands at 1.77. In other words for every 100,000 Thermo Fisher Scientific shares traded daily on the market, roughly 1770 shares are currently held short.

However Thermo Fisher Scientific's short interest can also be evaluated against the total number of Thermo Fisher Scientific shares, or, against the total number of tradable Thermo Fisher Scientific shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Thermo Fisher Scientific's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Thermo Fisher Scientific shares in existence, roughly 10 shares are currently held short) or 0.0066% of the tradable shares (for every 100,000 tradable Thermo Fisher Scientific shares, roughly 7 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Thermo Fisher Scientific.

Thermo Fisher Scientific's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Thermo Fisher Scientific's total ESG risk score

Total ESG risk: 14.69

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Thermo Fisher Scientific's environmental score

Environmental score: 2.11/100

Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Thermo Fisher Scientific's social score

Social score: 6.69/100

Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Thermo Fisher Scientific's governance score

Governance score: 3.38/100

Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Thermo Fisher Scientific's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.

Thermo Fisher Scientific share dividends

4%

Dividend payout ratio: 3.92% of net profits

Recently Thermo Fisher Scientific has paid out, on average, around 3.92% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.17% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $0.96 per share.

While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.

Thermo Fisher Scientific's most recent dividend payout was on 15 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2021 (the "ex-dividend date").

Have Thermo Fisher Scientific's shares ever split?

Thermo Fisher Scientific's shares were split on a 3:2 basis on 6 June 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.

Thermo Fisher Scientific share price volatility

Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as $432.8263 up to $616.93. A popular way to gauge a stock's volatility is its "beta".

TMO.US volatility(beta: 0.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.7259. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).

Thermo Fisher Scientific overview

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site